Citations (156)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Xiangxun Chen, Mengxi Zhou, Wenjie Fan, Mingwei Yang & Lin Yang. (2021) Combination of Sodium Cantharidinate with Cisplatin Synergistically Hampers Growth of Cervical Cancer. Drug Design, Development and Therapy 15, pages 171-183.
Read now
Read now
Yalin Liu, Longfei Liu & Feizhou Zhu. (2019) Therapies targeting the signal pathways of pheochromocytoma and paraganglioma. OncoTargets and Therapy 12, pages 7227-7241.
Read now
Read now
Xiaohong Xu, Vinothkumar Rajamanickam, Sheng Shu, Zhoudi Liu, Tao Yan, Jinxin He, Zhiguo Liu, Guilong Guo, Guang Liang & Yi Wang. (2019) Indole-2-Carboxamide Derivative LG25 Inhibits Triple-Negative Breast Cancer Growth By Suppressing Akt/mTOR/NF-κB Signalling Pathway. Drug Design, Development and Therapy 13, pages 3539-3550.
Read now
Read now
Cristiana Tanase, Radu Albulescu & Monica Neagu. (2016) Proteomic Approaches for Biomarker Panels in Cancer. Journal of Immunoassay and Immunochemistry 37:1, pages 1-15.
Read now
Read now
Francesca Sanguedolce, Antonella Cormio, Pantaleo Bufo, Giuseppe Carrieri & Luigi Cormio. (2015) Molecular markers in bladder cancer: Novel research frontiers. Critical Reviews in Clinical Laboratory Sciences 52:5, pages 242-255.
Read now
Read now
Arunkumar Arumugam, Pamela Agullo, Thiyagarajan Boopalan, Sushmita Nandy, Rebecca Lopez, Christina Gutierrez, Mahesh Narayan & Lakshmanaswamy Rajkumar. (2014) Neem leaf extract inhibits mammary carcinogenesis by altering cell proliferation, apoptosis, and angiogenesis. Cancer Biology & Therapy 15:1, pages 26-34.
Read now
Read now
Yu Lei, Hong-Xia Li, Wen-Sen Jin, Wan-Ren Peng, Cong-Jun Zhang, Li-Jia Bu, Ying-Ying Du, Tai Ma & Guo-Ping Sun. (2013) The radiosensitizing effect of Paeonol on lung adenocarcinoma by augmentation of radiation-induced apoptosis and inhibition of the PI3K/Akt pathway. International Journal of Radiation Biology 89:12, pages 1079-1086.
Read now
Read now
William A Denny. (2013) Phosphoinositide 3-kinase α inhibitors: a patent review. Expert Opinion on Therapeutic Patents 23:7, pages 789-799.
Read now
Read now
Aijaz Parray, Hifzur R Siddique, Sanjeev Nanda, Badrinath R Konety & Mohammad Saleem. (2012) Castration-resistant prostate cancer: potential targets and therapies. Biologics: Targets and Therapy 6, pages 267-276.
Read now
Read now
Dae-Dong Kim & Cathy Eng. (2012) The promise of mTOR inhibitors in the treatment of colorectal cancer. Expert Opinion on Investigational Drugs 21:12, pages 1775-1788.
Read now
Read now
Wei-Qiong Yang & Yi Zhang. (2012) RNAi-mediated gene silencing in cancer therapy. Expert Opinion on Biological Therapy 12:11, pages 1495-1504.
Read now
Read now
Marjory
Alana Marcello, Aline
Castaldi Sampaio, Bruno Geloneze, Ana
Carolina Junqueira Vasques, Ligia
Vera Montalli Assumpção & Laura
Sterian Ward. (2012) Obesity and Excess Protein and Carbohydrate Consumption Are Risk Factors for Thyroid Cancer. Nutrition and Cancer 64:8, pages 1190-1195.
Read now
Read now
Articles from other publishers (144)
Hongyan Lin, Dongxuan Ai, Qingqing Liu, Xinling Wang, Qingqing Chen, Zhongbin Hong, Yuheng Tao, Jian Gao & Liqun Wang. (2024) Natural isoflavone glabridin targets PI3Kγ as an adjuvant to increase the sensitivity of MDA-MB-231 to tamoxifen and DU145 to paclitaxel. The Journal of Steroid Biochemistry and Molecular Biology 236, pages 106426.
Crossref
Crossref
Xuesong Liu, Mengzhu Lv, Weimin Zhang & Qimin Zhan. (2023) Dysregulation of cholesterol metabolism in cancer progression. Oncogene 42:45, pages 3289-3302.
Crossref
Crossref
Ke Yang, Jun-Qi Wang, Kai Li, Su-Ning Chen & Fei Yu. (2023) Pseudolaric acid B induces apoptosis associated with the mitochondrial and PI3K/AKT/mTOR pathways in triple‑negative breast cancer. Oncology Reports 50:5.
Crossref
Crossref
Rana Aldabbas, Olfat G. Shaker, Manal F. Ismail & Nevine Fathy. (2022) miRNA-559 and MTDH as possible diagnostic markers of psoriasis: Role of PTEN/AKT/FOXO pathway in disease pathogenesis. Molecular and Cellular Biochemistry 478:7, pages 1427-1438.
Crossref
Crossref
Guangying Zhou & Shasha Wang. (2023) YTHDC2 Retards Cell Proliferation and Triggers Apoptosis in Papillary Thyroid Cancer by Regulating CYLD-Mediated Inactivation of Akt Signaling. Applied Biochemistry and Biotechnology.
Crossref
Crossref
Zhen Yang, Ruxue Liu, Minghan Qiu, Hanwei Mei, Jie Hao, Teng Song, Ke Zhao, Dandan Zou, Huaqing Wang & Ming Gao. (2023) The roles of ERIANIN in tumor and innate immunity and its’ perspectives in immunotherapy. Frontiers in Immunology 14.
Crossref
Crossref
Alireza Mafi, Malihe Rezaee, Neda Hedayati, Sara Diana Hogan, Russel J. Reiter, Mohammad-Hossein Aarabi & Zatollah Asemi. (2023) Melatonin and 5-fluorouracil combination chemotherapy: opportunities and efficacy in cancer therapy. Cell Communication and Signaling 21:1.
Crossref
Crossref
Chuchu Li, Yuqiao Han, Zhengyang Wang, Yanan Yu, Chen Wang, Ziwei Ren, Yanzhi Guo, Tong Zhu, XuWen Li, Suzhen Dong & Mingliang Ma. (2023) Function-oriented synthesis of Imidazo[1,2-a]pyrazine and Imidazo[1,2-b]pyridazine derivatives as potent PI3K/mTOR dual inhibitors. European Journal of Medicinal Chemistry 247, pages 115030.
Crossref
Crossref
Zhongyue Ren, Shufang Chen, Huihui Lv, Lingling Peng, Wanyu Yang, Jiahui Chen, Zhihua Wu & Cuixiang Wan. (2022) Effect of Bifidobacterium animalis subsp. lactis SF on enhancing the tumor suppression of irinotecan by regulating the intestinal flora. Pharmacological Research 184, pages 106406.
Crossref
Crossref
Gilles Kermoison & Ciprian Draganescu. (2022) Role of Dietary and Environmental Factors on Thyroid Cancer in Romania: A Brief Review. Diagnostics 12:8, pages 1959.
Crossref
Crossref
Devesh Tewari, Pooja Patni, Anusha Bishayee, Archana N. Sah & Anupam Bishayee. (2022) Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: A novel therapeutic strategy. Seminars in Cancer Biology 80, pages 1-17.
Crossref
Crossref
Rongxin Geng, Xiaonan Zhu, Xiang Tao, Junhui Liu & Haitao Xu. (2022) EIF1A depletion restrains human pituitary adenoma progression. Translational Oncology 15:1, pages 101299.
Crossref
Crossref
Bhuvanadas Sreeshma, Anjali P. Patni, Rajib Dhar & Arikketh Devi. 2022. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
2153
2177
.
Bhuvanadas Sreeshma, Anjali P. Patni, Rajib Dhar & Arikketh Devi. 2021. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
1
26
.
Jian ZhouZhen-yu TangXiao-liang Sun. (2021) RNF38 inhibits osteosarcoma cell proliferation by binding to CRY1. Biochemistry and Cell Biology 99:5, pages 629-635.
Crossref
Crossref
Heitor Gomes de Araújo‐Filho, Jucilene F. dos Santos, Mikaella T. B. Carvalho, Laurent Picot, Ingrid Fruitier‐Arnaudin, Hugo Groult, Lucindo J. Quintans‐Júnior & Jullyana S.S. Quintans. (2021) Anticancer activity of limonene: A systematic review of target signaling pathways. Phytotherapy Research 35:9, pages 4957-4970.
Crossref
Crossref
Yueqin Feng & Fengjin Hao. (2021) Hansenia weberbaueriana (Fedde ex H.Wolff) Pimenov & Kljuykov Extract Suppresses Proliferation of HepG2 Cells via the PTEN-PI3K-AKT Pathway Uncovered by Integrating Network Pharmacology and Iin Vitro Experiments. Frontiers in Pharmacology 12.
Crossref
Crossref
Seiya Inoue, Takahiro Yoshida, Takeshi Nishino, Masakazu Goto, Mariko Aoyama, Naoya Kawakita, Yota Yamamoto, Furukita Yoshihito, Hiromitsu Takizawa & Akira Tangoku. (2021) Biomarkers predicting the response to chemotherapy and the prognosis in patients with esophageal squamous cell carcinoma. General Thoracic and Cardiovascular Surgery 69:3, pages 525-533.
Crossref
Crossref
Xiaoguang Yang, Dongxue Zhao, Yanfeng Li, Yanyu Li, Wei Cui, Yuxin Li, Han Li, Xinyu Li & Dun Wang. (2020) Potential monoamine oxidase A inhibitor suppressing paclitaxel‐resistant non‐small cell lung cancer metastasis and growth. Thoracic Cancer 11:10, pages 2858-2866.
Crossref
Crossref
Jian Li, Li Jiang, Zhu Liu, Yanguo Li, Yang Xu & Hongwei Liu. (2020) Oncogenic pseudogene DUXAP10 knockdown suppresses proliferation and invasion and induces apoptosis of papillary thyroid carcinoma cells by inhibition of Akt/mTOR pathway. Clinical and Experimental Pharmacology and Physiology 47:8, pages 1473-1483.
Crossref
Crossref
Guang-Hui Qi, Chun-Hui Wang, Hong-Ge Zhang, Jian-Guo Yu, Fei Ding, Zhi-Chao Song & Qing-Hua Xia. (2020)
Comprehensive analysis of the effect of rs2295080 and rs2536 polymorphisms within the
mTOR
gene on cancer risk
. Bioscience Reports 40:7.
Crossref
Crossref
Julia A. Loos, Perla Negro & Andrea C. Cumino. (2020) In vitro anti-echinococcal activity of octreotide: Additive effect of metformin linked to autophagy. Acta Tropica 203, pages 105312.
Crossref
Crossref
Durgesh Nandini Das & Prashanta Kumar Panda. 2020. Autophagy in tumor and tumor microenvironment. Autophagy in tumor and tumor microenvironment
1
34
.
Tao Wang, Tao Peng, Xiaoxue Wen, Gang Wang, Yunbo Sun, Shuchen Liu, Shouguo Zhang & Lin Wang. (2019) Design, Synthesis and Preliminary Biological Evaluation of Benzylsulfone Coumarin Derivatives as Anti-Cancer Agents. Molecules 24:22, pages 4034.
Crossref
Crossref
Xiao‐Qing Zhang, Chang Yao, Wei‐He Bian, Xu Chen, Jing‐Xian Xue, Zhi‐Yuan Zhu, Yu Ying, Yan Lei Xu & Cong Wang. (2019) Effects of Astragaloside IV on treatment of breast cancer cells execute possibly through regulation of Nrf2 via PI3K/AKT/mTOR signaling pathway. Food Science & Nutrition 7:11, pages 3403-3413.
Crossref
Crossref
Jin Wang, Hong-Ying Wang, Ying Shen, Dong Liang, Hui-Yan Wang, San-Qi Zhang, Yong-Xiao Cao & Lei Cao. (2019) A novel small-molecule PI3K/Akt signaling inhibitor, W934, exhibits potent antitumor efficacy in A549 non-small-cell lung cancer. Anti-Cancer Drugs 30:9, pages 900-908.
Crossref
Crossref
Sravanthi Shastri, Bhaswati Chatterjee & Suman S. Thakur. (2019) Achievements in Cancer Research and its Therapeutics in Hundred Years. Current Topics in Medicinal Chemistry 19:17, pages 1545-1562.
Crossref
Crossref
Zongjuan Li, Yang Zhang, Ruonan Wang, Kun Zou & Lijuan Zou. (2019) Genetic alterations in anaplastic thyroid carcinoma and targeted therapies (Review). Experimental and Therapeutic Medicine.
Crossref
Crossref
Shilpa Kuttikrishnan, Kodappully S. Siveen, Kirti S. Prabhu, Abdul Quaiyoom Khan, Eiman I. Ahmed, Sabah Akhtar, Tayyiba A. Ali, Maysaloun Merhi, Said Dermime, Martin Steinhoff & Shahab Uddin. (2019) Curcumin Induces Apoptotic Cell Death via Inhibition of PI3-Kinase/AKT Pathway in B-Precursor Acute Lymphoblastic Leukemia. Frontiers in Oncology 9.
Crossref
Crossref
Xiaokang Wang, Jianghong Liu, Zhanxiong Xie, Jiaoyu Rao, Gengrui Xu, Kaiyuan Huang, Wenyan Li & Zijun Yin. (2019) Chlorogenic acid inhibits proliferation and induces apoptosis in A498 human kidney cancer cells via inactivating PI3K/Akt/mTOR signalling pathway. Journal of Pharmacy and Pharmacology 71:7, pages 1100-1109.
Crossref
Crossref
Rui Zeng, Yuanke Liang, Muhammad Umer Farooq, Yujie Zhang, Hla Hla Ei, Zhichen Tang, Tengda Zheng, Yang Su, Xiaoying Ye, Xiaomei Jia & Jianqing Zhu. (2019) Alterations in transcriptome and antioxidant activity of naturally aged mice exposed to selenium-rich rice. Environmental Science and Pollution Research 26:17, pages 17834-17844.
Crossref
Crossref
Sandra M. Ayuk & Heidi Abrahamse. (2019) mTOR Signaling Pathway in Cancer Targets Photodynamic Therapy In Vitro. Cells 8:5, pages 431.
Crossref
Crossref
Joshua Li, Wai-Yee Ho, Julia Y S Tsang, Yun-Bi Ni, Siu-Ki Chan & Gary M Tse. (2019) Expression of biomarkers in the AKT pathway correlates with malignancy and recurrence in phyllodes tumours of the breast. Histopathology 74:4, pages 567-577.
Crossref
Crossref
Dajiang Wu, Hao Zhang, Fang Ji & Wenbin Ding. (2019) MicroRNA-17 promotes osteosarcoma cells proliferation and migration and inhibits apoptosis by regulating SASH1 expression. Pathology - Research and Practice 215:1, pages 115-120.
Crossref
Crossref
M. B. Mogensen, M. Rossing, O. Østrup, P. N. Larsen, P. J. Heiberg Engel, L. N. Jørgensen, E. V. Hogdall, J. Eriksen, P. Ibsen, P. Jess, M. Grauslund, H. J. Nielsen, F. C. Nielsen, B. Vainer & K. Osterlind. (2018) Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing. BMC Cancer 18:1.
Crossref
Crossref
Mahdi Hatamipour, Mahin Ramezani, Sayyed Abolghasem Sajadi Tabassi, Thomas P. Johnston, Mahnaz Ramezani & Amirhosein Sahebkar. (2018) Demethoxycurcumin: A naturally occurring curcumin analogue with antitumor properties. Journal of Cellular Physiology 233:12, pages 9247-9260.
Crossref
Crossref
Xin You, Yixin Zhao, Jing Sui, Xianbiao Shi, Yulu Sun, Jiahan Xu, Geyu Liang, Qingxiang Xu & Yongzhong Yao. (2018) Integrated analysis of long noncoding RNA interactions reveals the potential role in progression of human papillary thyroid cancer. Cancer Medicine 7:11, pages 5394-5410.
Crossref
Crossref
Yi Yang, Yingfei Sun, Jinrui Xu, Kangda Bao, Meihui Luo, Xiaoming Liu & Yujiong Wang. (2018)
Epithelial Cells Attenuate Toll-Like Receptor-Mediated Inflammatory Responses in Monocyte-Derived Macrophage-Like Cells to
Mycobacterium tuberculosis
by Modulating the PI3K/Akt/mTOR Signaling Pathway
. Mediators of Inflammation 2018, pages 1-19.
Crossref
Crossref
Yuheng Du, Daojiang Li, Nanpeng Li, Chen Su, Chunxing Yang, Changwei Lin, Miao Chen, Runliu Wu, Xiaorong Li & Gui Hu. (2018) POFUT1 promotes colorectal cancer development through the activation of Notch1 signaling. Cell Death & Disease 9:10.
Crossref
Crossref
Immacolata Nettore, Annamaria Colao & Paolo Macchia. (2018) Nutritional and Environmental Factors in Thyroid Carcinogenesis. International Journal of Environmental Research and Public Health 15:8, pages 1735.
Crossref
Crossref
Qiao Yi Chen & Max Costa. (2018) PI3K/Akt/mTOR Signaling Pathway and the Biphasic Effect of Arsenic in Carcinogenesis. Molecular Pharmacology 94:1, pages 784-792.
Crossref
Crossref
Ying-Ze Zheng & Lei Liang. (2018) High expression of PXDN is associated with poor prognosis and promotes proliferation, invasion as well as migration in ovarian cancer. Annals of Diagnostic Pathology 34, pages 161-165.
Crossref
Crossref
Miao Fang, Daoqi Zhu, Chaohua Luo, Chan Li, Chen Zhu, Jinying Ou, Hancheng Li, Yuting Zhou, Chuying Huo, Wei Liu, Jiangli Peng, Qiuxian Peng & Zhixian Mo. (2018) In vitro and in vivo anti-malignant melanoma activity of Alocasia cucullata via modulation of the phosphatase and tensin homolog/phosphoinositide 3-kinase/AKT pathway. Journal of Ethnopharmacology 213, pages 359-365.
Crossref
Crossref
Afsane Bahrami, Majid Khazaei, Malihe Hasanzadeh, Soodabeh ShahidSales, Mona Joudi Mashhad, Marjaneh Farazestanian, Hamid Reza Sadeghnia, Majid Rezayi, Mina Maftouh, Seyed Mahdi Hassanian & Amir Avan. (2017) Therapeutic Potential of Targeting PI3K/AKT Pathway in Treatment of Colorectal Cancer: Rational and Progress. Journal of Cellular Biochemistry 119:3, pages 2460-2469.
Crossref
Crossref
Mi Choi, Sung‑Min Moon, Seul Lee, Bo‑Ram Park, Jae‑Sung Kim, Do Kim, Yong Kim & Chun Kim. (2018) Adenosine induces intrinsic apoptosis via the PI3K/Akt/mTOR signaling pathway in human pharyngeal squamous carcinoma FaDu cells. Oncology Letters.
Crossref
Crossref
Vasanti Suvarna, Manikanta Murahari, Tabassum Khan, Pramila Chaubey & Preeti Sangave. (2017) Phytochemicals and PI3K Inhibitors in Cancer—An Insight. Frontiers in Pharmacology 8.
Crossref
Crossref
Yanxia Huang, Jing Zhang, Lidan Hou, Ge Wang, Hui Liu, Rui Zhang, Xiaoyu Chen & Jinshui Zhu. (2017) LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway. Journal of Experimental & Clinical Cancer Research 36:1.
Crossref
Crossref
Youcef Derbal. (2017) Perspective on the dynamics of cancer. Theoretical Biology and Medical Modelling 14:1.
Crossref
Crossref
Chun-Guang Wang, Liang Zhong, Yong-Li Liu, Xue-Jun Shi, Long-Qin Shi, Li Zeng & Bei-Zhong Liu. (2016) Emodin Exerts an Antiapoptotic Effect on Human Chronic Myelocytic Leukemia K562 Cell Lines by Targeting the PTEN/PI3K-AKT Signaling Pathway and Deleting BCR-ABL. Integrative Cancer Therapies 16:4, pages 526-539.
Crossref
Crossref
Winn Aung, Atsushi B Tsuji, Hitomi Sudo, Aya Sugyo, Yoshinori Ukai, Katsushi Kouda, Yoshikazu Kurosawa, Takako Furukawa, Tsuneo Saga & Tatsuya Higashi. (2017)
Combined treatment of pancreatic cancer xenograft with
90
Y-ITGA6B4-mediated radioimmunotherapy and PI3K/mTOR inhibitor
. World Journal of Gastroenterology 23:42, pages 7551-7562.
Crossref
Crossref
Qiongyu Li, Zijun Lai, Zhaokun Yan, Jun Peng, Yiyi Jin, Lihui Wei & Jiumao Lin. (2017) Hedyotis�diffusa Willd inhibits proliferation and induces apoptosis of 5‑FU resistant colorectal cancer cells by regulating the PI3K/AKT signaling pathway. Molecular Medicine Reports.
Crossref
Crossref
Li Li, Ru Feng, Qian Xu, Feiyue Zhang, Tong Liu, Jiang Cao & Sujuan Fei. (2017) Expression of the β3 subunit of Na+/K+-ATPase is increased in gastric cancer and regulates gastric cancer cell progression and prognosis via the PI3/AKT pathway. Oncotarget 8:48, pages 84285-84299.
Crossref
Crossref
Kang-Seo Park, Hannah Yang, Junyoung Choi, Seyoung Seo, Deokhoon Kim, Chang Hoon Lee, Hanwool Jeon, Sang-We Kim & Dae Ho Lee. (2017) The HSP90 inhibitor, NVP-AUY922, attenuates intrinsic PI3K inhibitor resistance in KRAS-mutant non-small cell lung cancer. Cancer Letters 406, pages 47-53.
Crossref
Crossref
Xingyan Ju, Shihai liu, Donghai Liang, Tao Jiang, Ronghui Yuan, Wei Zhao & Hongsheng Yu. (2017) Effect of low dose fractionated radiation on reversing cisplatin resistance in ovarian carcinoma via VEGF and mTOR ⁎. Oncology and Translational Medicine 3:4, pages 143-150.
Crossref
Crossref
Yi Xu, Jian-yong Zhu, Zhang-ming Lei, Li-jun Wan, Xiu-wen Zhu, Feng Ye & Yan-yue Tong. (2016) Anti-proliferative effects of paeonol on human prostate cancer cell lines DU145 and PC-3. Journal of Physiology and Biochemistry 73:2, pages 157-165.
Crossref
Crossref
Zhenhua Du & Xianqun Sha. (2017) Demethoxycurcumin inhibited human epithelia ovarian cancer cells’ growth via up-regulating miR-551a. Tumor Biology 39:3, pages 101042831769430.
Crossref
Crossref
Michela Palmieri, Rituraj Pal, Hemanth R. Nelvagal, Parisa Lotfi, Gary R. Stinnett, Michelle L. Seymour, Arindam Chaudhury, Lakshya Bajaj, Vitaliy V. Bondar, Laura Bremner, Usama Saleem, Dennis Y. Tse, Deepthi Sanagasetti, Samuel M. Wu, Joel R. Neilson, Fred A. Pereira, Robia G. Pautler, George G. Rodney, Jonathan D. Cooper & Marco Sardiello. (2017) mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases. Nature Communications 8:1.
Crossref
Crossref
Ying Zhang, Bo Zhang, Zhao-Lian Wei, Wen-Jie Lv, Yuan-Yuan Yang & Ya Chen. (2017) Diagnostic Significance of Phosphoinositide 3-Kinase and Mammalian Target of Rapamycin Complex 1 in Preeclampsia. Reproductive Sciences 24:2, pages 268-275.
Crossref
Crossref
Anya Alayev, Rachel S. Salamon, Naomi S. Schwartz, Adi Y. Berman, Sara L. Wiener & Marina K. Holz. (2017) Combination of Rapamycin and Resveratrol for Treatment of Bladder Cancer. Journal of Cellular Physiology 232:2, pages 436-446.
Crossref
Crossref
Min Ho Han, Dae-Sung Lee, Jin-Woo Jeong, Su-Hyun Hong, Il-Whan Choi, Hee-Jae Cha, Suhkmann Kim, Heui-Soo Kim, Cheol Park, Gi-Young Kim, Sung-Kwon Moon, Wun-Jae Kim & Yung Hyun Choi. (2017) Fucoidan Induces ROS-Dependent Apoptosis in 5637 Human Bladder Cancer Cells by Downregulating Telomerase Activity via Inactivation of the PI3K/Akt Signaling Pathway. Drug Development Research 78:1, pages 37-48.
Crossref
Crossref
Nikolaos Koletsas, Triantafyllia Koletsa, Spyros Choidas, Konstantinos Anagnostopoulos, Stavros Touloupidis, Thomas Zaramboukas, Georgia Raptou, Nikolaos Papadopoulos & Maria Lambropoulou. (2017) Immunohistochemical Investigation of HER/AKT/mTOR Pathway and Cellular Adhesion Molecules in Urothelial Carcinomas. Pathology Research International 2017, pages 1-7.
Crossref
Crossref
Chieh-Hsiang Lu, Shu-Hsin Chen, Yi-Sheng Chang, Yi-Wen Liu, Jin-Yi Wu, Yun-Ping Lim, Hui-I Yu & Ying-Ray Lee. (2017) Honokiol, a potential therapeutic agent, induces cell cycle arrest and program cell death in vitro and in vivo in human thyroid cancer cells. Pharmacological Research 115, pages 288-298.
Crossref
Crossref
Sayak Bhattacharya, Kevin E. McElhanon, Liubov V. Gushchina & Noah Weisleder. (2016) Role of phosphatidylinositol-4,5-bisphosphate 3-kinase signaling in vesicular trafficking. Life Sciences 167, pages 39-45.
Crossref
Crossref
Yun-Xin Lu, Dong-Liang Chen, De-Shen Wang, Le-Zong Chen, Hai-Yu Mo, Hui Sheng, Long Bai, Qi-Nian Wu, Hong-En Yu, Dan Xie, Jing-Ping Yun, Zhao-Lei Zeng, Feng Wang, Huai-Qiang Ju & Rui-Hua Xu. (2016) Melatonin enhances sensitivity to fluorouracil in oesophageal squamous cell carcinoma through inhibition of Erk and Akt pathway. Cell Death & Disease 7:10, pages e2432-e2432.
Crossref
Crossref
Wei Gong, Jian Zheng, Xiaobai Liu, Jun Ma, Yunhui Liu & Yixue Xue. (2016)
Knockdown of
NEAT1
restrained the malignant progression of glioma stem cells by activating microRNA
let-7e
. Oncotarget 7:38, pages 62208-62223.
Crossref
Crossref
Jianzong Li, Haiyang Wang, Junjie Li, Jinku Bao & Chuanfang Wu. (2016) Discovery of a Potential HER2 Inhibitor from Natural Products for the Treatment of HER2-Positive Breast Cancer. International Journal of Molecular Sciences 17:7, pages 1055.
Crossref
Crossref
Feng Chen, Xiaochi Chen, Deyong Yang, Xiangyu Che, Jianbo Wang, Xiancheng Li, Zhiwei Zhang, Qifei Wang, Wei Zheng, Lina Wang, Xuejian Wang & Xishuang Song. (2016) Isoquercitrin inhibits bladder cancer progression in vivo and in�vitro by regulating the PI3K/Akt and PKC signaling pathways. Oncology Reports.
Crossref
Crossref
Meng‑Hua Dong, Qian Zhang, Yuan‑Yuan Wang, Bai‑Sui Zhou, Yu‑Fei Sun & Qiang Fu. (2016) Euphorbia fischeriana Steud inhibits malignant melanoma via modulation of the phosphoinositide-3-kinase/Akt signaling pathway. Experimental and Therapeutic Medicine.
Crossref
Crossref
Wooseok Han, Daniel L. Menezes, Yongjin Xu, Mark S. Knapp, Robert Elling, Matthew T. Burger, Zhi-Jie Ni, Aaron Smith, Jiong Lan, Teresa E. Williams, Joelle Verhagen, Kay Huh, Hanne Merritt, John Chan, Susan Kaufman, Charles F. Voliva & Sabina Pecchi. (2016) Discovery of imidazo[1,2-a]-pyridine inhibitors of pan-PI3 kinases that are efficacious in a mouse xenograft model. Bioorganic & Medicinal Chemistry Letters 26:3, pages 742-746.
Crossref
Crossref
Matthew J. Nemec, Hyemee Kim, Alexandria B. Marciante, Ryan C. Barnes, Stephen T. Talcott & Susanne U. Mertens-Talcott. (2016) Pyrogallol, an absorbable microbial gallotannins-metabolite and mango polyphenols (Mangifera Indica L.) suppress breast cancer ductal carcinoma in situ proliferation in vitro. Food & Function 7:9, pages 3825-3833.
Crossref
Crossref
ZHENYU LIN, HONG MEI, JIQUAN FAN, ZHONGYUAN YIN & GANG WU. (2015) Effect of the dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against human Merkel cell carcinoma MKL-1 cells. Oncology Letters 10:6, pages 3663-3667.
Crossref
Crossref
HA-NA WOO, WON IL LEE, JI HYUN KIM, JEONGHYUN AHN, JEONG HEE HAN, SUE YEON LIM, WON WOO LEE & HEUIRAN LEE. (2015) Combined antitumor gene therapy with herpes simplex virus-thymidine kinase and short hairpin RNA specific for mammalian target of rapamycin. International Journal of Oncology 47:6, pages 2233-2239.
Crossref
Crossref
Maqbool Ahmed, Azhar R Hussain, Abdul K. Siraj, Shahab Uddin, Nasser Al-Sanea, Fouad Al-Dayel, Mohammed Al-Assiri, Shaham Beg & Khawla S. Al-Kuraya. (2015) Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells. Molecular Cancer 14:1.
Crossref
Crossref
Jennifer Wheler, Roman Yelensky, Gerald Falchook, Kevin B Kim, Patrick Hwu, Apostolia M Tsimberidou, Philip J Stephens, David Hong, Maureen T Cronin & Razelle Kurzrock. (2015) Next generation sequencing of exceptional responders with BRAF-mutant melanoma: implications for sensitivity and resistance. BMC Cancer 15:1.
Crossref
Crossref
Chandra Bartholomeusz, Xuemei Xie, Mary Kathryn Pitner, Kimie Kondo, Ali Dadbin, Jangsoon Lee, Hitomi Saso, Paul D. Smith, Kevin N. Dalby & Naoto T. Ueno. (2015) MEK Inhibitor Selumetinib (AZD6244; ARRY-142886) Prevents Lung Metastasis in a Triple-Negative Breast Cancer Xenograft Model. Molecular Cancer Therapeutics 14:12, pages 2773-2781.
Crossref
Crossref
A A Baxter, M D Hulett & I KH Poon. (2015) The phospholipid code: a key component of dying cell recognition, tumor progression and host–microbe interactions. Cell Death & Differentiation 22:12, pages 1893-1905.
Crossref
Crossref
Lu Guo, Hua Wu, Jinghong Zhu, Caixia Zhang, Jianxiu Ma, Jianfa Lan & Xiaodong Xie. (2015) Genetic variations in the PI3K/AKT pathway predict platinum-based neoadjuvant chemotherapeutic sensitivity in squamous cervical cancer. Life Sciences 143, pages 217-224.
Crossref
Crossref
Xiaocen Chang, Yuyan Zhao, Shujing Ju & Lei Guo. (2015) Orexin-A regulates cell apoptosis in human H295R adrenocortical cells via orexin receptor type�1 through the AKT signaling pathway. Molecular Medicine Reports.
Crossref
Crossref
Mingming Liu, Zihao Qi, Bingzhi Liu, Yi Ren, Hanbin Li, Gong Yang & Qian Zhang. (2015) RY-2f, an isoflavone analog, overcomes cisplatin resistance to inhibit ovarian tumorigenesis via targeting the PI3K/AKT/mTOR signaling pathway. Oncotarget 6:28, pages 25281-25294.
Crossref
Crossref
WEIJIA WANG, YI TU, SHANSHAN WANG, SHAN XU, LINLIN XU, YIFENG XIONG, JINHONG MEI & CHUNLIANG WANG. (2015) Role of HER-2 activity in the regulation of malignant meningioma cell proliferation and motility. Molecular Medicine Reports 12:3, pages 3575-3582.
Crossref
Crossref
T Soussi & K G Wiman. (2015) TP53: an oncogene in disguise. Cell Death & Differentiation 22:8, pages 1239-1249.
Crossref
Crossref
Marius VantlerJoana JesusOlli LeppänenMaximilian SchernerEva Maria BerghausenLenard MustafovXin ChenTilmann KramerMario ZierdenMaximilian GerhardtHenrik ten FreyhausFlorian BlaschkeAnja Sterner-KockStephan BaldusJean J. ZhaoStephan Rosenkranz. (2015) Class IA Phosphatidylinositol 3-Kinase Isoform p110α Mediates Vascular Remodeling. Arteriosclerosis, Thrombosis, and Vascular Biology 35:6, pages 1434-1444.
Crossref
Crossref
Doriano Fabbro, Sandra W Cowan-Jacob & Henrik Moebitz. (2015) Ten things you should know about protein kinases: IUPHAR Review 14. British Journal of Pharmacology 172:11, pages 2675-2700.
Crossref
Crossref
Analia Azaro, Jordi Rodon, Antonio Calles, Irene Braña, Manuel Hidalgo, Pedro P. Lopez-Casas, Manuel Munoz, Paul Westwood, Joel Miller, Brian A. Moser, Ute Ohnmacht, William Bumgardner, Karim A. Benhadji & Emiliano Calvo. (2015) A first-in-human phase I trial of LY2780301, a dual p70 S6 kinase and Akt Inhibitor, in patients with advanced or metastatic cancer. Investigational New Drugs 33:3, pages 710-719.
Crossref
Crossref
Anabel Gil, Isabel Rodríguez-Escudero, Miriam Stumpf, María Molina, Víctor J. Cid & Rafael Pulido. (2015) A Functional Dissection of PTEN N-Terminus: Implications in PTEN Subcellular Targeting and Tumor Suppressor Activity. PLOS ONE 10:4, pages e0119287.
Crossref
Crossref
Lorella Maniscalco. (2015) Canine osteosarcoma: Understanding its variability to improve treatment. The Veterinary Journal 203:2, pages 135-136.
Crossref
Crossref
Julia C. Meier, Bernard Haendler, Henrik Seidel, Philip Groth, Robert Adams, Karl Ziegelbauer, Bertolt Kreft, Georg Beckmann, Anette Sommer & Charlotte Kopitz. (2014) Knockdown of platinum‐induced growth differentiation factor 15 abrogates p27‐mediated tumor growth delay in the chemoresistant ovarian cancer model A2780cis. Cancer Medicine 4:2, pages 253-267.
Crossref
Crossref
Y-C Cheng, P-H Chen, H-Y Chiang, C-S Suen, M-J Hwang, T-Y Lin, H-C Yang, W-C Lin, P-L Lai & S-Y Shieh. (2015) Candidate tumor suppressor B-cell translocation gene 3 impedes neoplastic progression by suppression of AKT. Cell Death & Disease 6:1, pages e1584-e1584.
Crossref
Crossref
GA BIN PARK, DAE-JIN KIM, YEONG-SEOK KIM, HYUN-KYUNG LEE, CHANG WAN KIM & DAE YOUNG HUR. (2015) Silencing of galectin-3 represses osteosarcoma cell migration and invasion through inhibition of FAK/Src/Lyn activation and β-catenin expression and increases susceptibility to chemotherapeutic agents. International Journal of Oncology 46:1, pages 185-194.
Crossref
Crossref
Nadine Houédé & Philippe Pourquier. (2015) Targeting the genetic alterations of the PI3K–AKT–mTOR pathway: Its potential use in the treatment of bladder cancers. Pharmacology & Therapeutics 145, pages 1-18.
Crossref
Crossref
Jacques RobertJacques Robert. 2015. Textbook of Cell Signalling in Cancer. Textbook of Cell Signalling in Cancer
43
54
.
Michael J. Flynn & Rebecca Kristeleit. 2015. Pelvic Cancer Surgery. Pelvic Cancer Surgery
327
341
.
HaiXia Li, JianFang Zeng & Keng Shen. (2014) PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer. Archives of Gynecology and Obstetrics 290:6, pages 1067-1078.
Crossref
Crossref
Bin Li, Jin Li, Wen Wen Xu, Xin Yuan Guan, Yan Ru Qin, Li Yi Zhang, Simon Law, Sai Wah Tsao & Annie L.M. Cheung. (2014) Suppression of esophageal tumor growth and chemoresistance by directly targeting the PI3K/AKT pathway. Oncotarget 5:22, pages 11576-11587.
Crossref
Crossref
Ruzica BagoNazma MalikMichael J. MunsonAlan R. PrescottPaul DaviesEeva SommerNatalia ShpiroRichard WardDarren CrossIan G. GanleyDario R. Alessi. (2014) Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase. Biochemical Journal 463:3, pages 413-427.
Crossref
Crossref
Tan Li & Guanyu Wang. (2014) Computer-Aided Targeting of the PI3K/Akt/mTOR Pathway: Toxicity Reduction and Therapeutic Opportunities. International Journal of Molecular Sciences 15:10, pages 18856-18891.
Crossref
Crossref
M. A. Marcello, P. Malandrino, J. F. M. Almeida, M. B. Martins, L. L. Cunha, N. E. Bufalo, G. Pellegriti & L. S. Ward. (2014) The influence of the environment on the development of thyroid tumors: a new appraisal. Endocrine Related Cancer 21:5, pages T235-T254.
Crossref
Crossref
Claudia Hofmann, Thorsten Stühmer, Nadine Schmiedl, Reinhard Wetzker, Anja Mottok, Andreas Rosenwald, Christian Langer, Josip Zovko, Manik Chatterjee, Hermann Einsele, Ralf C. Bargou & Torsten Steinbrunn. (2014) PI3K-dependent multiple myeloma cell survival is mediated by the PIK3CA isoform. British Journal of Haematology 166:4, pages 529-539.
Crossref
Crossref
Jason Boyang Wu, Chen Shao, Xiangyan Li, Qinlong Li, Peizhen Hu, Changhong Shi, Yang Li, Yi-Ting Chen, Fei Yin, Chun-Peng Liao, Bangyan L. Stiles, Haiyen E. Zhau, Jean C. Shih & Leland W.K. Chung. (2014) Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis. Journal of Clinical Investigation 124:7, pages 2891-2908.
Crossref
Crossref
Irem Dogan, Shigeru Kawabata, Emily Bergbower, Joell J. Gills, Abdullah Ekmekci, Willie WilsonIIIIII, Charles M. Rudin & Phillip A. Dennis. (2014) SOX2 expression is an early event in a murine model of EGFR mutant lung cancer and promotes proliferation of a subset of EGFR mutant lung adenocarcinoma cell lines. Lung Cancer 85:1, pages 1-6.
Crossref
Crossref
Hila Asraf, Shimrit Salomon, Andrey Nevo, Israel Sekler, Doris Mayer & Michal Hershfinkel. (2014) The ZnR/GPR39 Interacts With the CaSR to Enhance Signaling in Prostate and Salivary Epithelia. Journal of Cellular Physiology 229:7, pages 868-877.
Crossref
Crossref
Shigekuni Hosogi, Katsuyuki Kusuzaki, Toshio Inui, Xiangdong Wang & Yoshinori Marunaka. (2014) Cytosolic chloride ion is a key factor in lysosomal acidification and function of autophagy in human gastric cancer cell. Journal of Cellular and Molecular Medicine 18:6, pages 1124-1133.
Crossref
Crossref
E Hirsch, E Ciraolo, I Franco, A Ghigo & M Martini. (2013) PI3K in cancer–stroma interactions: bad in seed and ugly in soil. Oncogene 33:24, pages 3083-3090.
Crossref
Crossref
Morteza Esmaeili, Tone F. Bathen, Olav Engebråten, Gunhild M. Maelandsmo, Ingrid S. Gribbestad & Siver A. Moestue. (2014)
Quantitative
31
P HR-MAS MR spectroscopy for detection of response to PI3K/mTOR inhibition in breast cancer xenografts
. Magnetic Resonance in Medicine 71:6, pages 1973-1981.
Crossref
Crossref
Yujeong Jeong, Daeil Kwon & Sungwoo Hong. (2014) Selective and potent small-molecule inhibitors of PI3Ks. Future Medicinal Chemistry 6:7, pages 737-756.
Crossref
Crossref
Michael J. Donovan & Carlos Cordon-Cardo. (2014) Genomic analysis in active surveillance. Current Opinion in Urology 24:3, pages 303-310.
Crossref
Crossref
Alberto Bavelloni, Manuela Piazzi, Irene Faenza, Mirco Raffini, Antonietta D'Angelo, Luca Cattini, Lucio Cocco & William L. Blalock. (2014)
Prohibitin 2 represents a novel nuclear AKT substrate during all‐
trans
retinoic acid–induced differentiation of acute promyelocytic leukemia cells
. The FASEB Journal 28:5, pages 2009-2019.
Crossref
Crossref
Evanguelos Xylinas, Luis A. Kluth, Yair Lotan, Siamak Daneshmand, Malte Rieken, Pierre I. Karakiewicz & Shahrokh F. Shariat. (2014) Blood- and tissue-based biomarkers for prediction of outcomes in urothelial carcinoma of the bladder. Urologic Oncology: Seminars and Original Investigations 32:3, pages 230-242.
Crossref
Crossref
Pushpendra Singh & Felix Bast. (2013) Multitargeted molecular docking study of plant-derived natural products on phosphoinositide-3 kinase pathway components. Medicinal Chemistry Research 23:4, pages 1690-1700.
Crossref
Crossref
Byron K.Y. Bitanihirwe, Mayura Meerang, Martina Friess, Alex Soltermann, Lukas Frischknecht, Svenja Thies, Emanuela Felley-Bosco, Ming-Sound Tsao, Ghassan Allo, Marc de Perrot, Burkhardt Seifert, Holger Moch, Rolf Stahel, Walter Weder & Isabelle Opitz. (2014) PI3K/mTOR Signaling in Mesothelioma Patients Treated with Induction Chemotherapy Followed by Extrapleural Pneumonectomy. Journal of Thoracic Oncology 9:2, pages 239-247.
Crossref
Crossref
Sebastian KugerEmre CörekBülent PolatUlrike KämmererMichael FlentjeCholpon S. Djuzenova. (2014) Novel PI3K and mTOR Inhibitor NVP-BEZ235 Radiosensitizes Breast Cancer Cell Lines under Normoxic and Hypoxic Conditions. Breast Cancer: Basic and Clinical Research 8, pages BCBCR.S13693.
Crossref
Crossref
Jing Shi. (2014) Pathogenetic mechanisms in gastric cancer. World Journal of Gastroenterology 20:38, pages 13804.
Crossref
Crossref
Jin Wang, Jianjun Chen, Duane D. Miller & Wei Li. (2014) Synergistic Combination of Novel Tubulin Inhibitor ABI-274 and Vemurafenib Overcomes Vemurafenib Acquired Resistance in BRAFV600E Melanoma. Molecular Cancer Therapeutics 13:1, pages 16-26.
Crossref
Crossref
Alfonso Latorre, Christian Posch, Yolanda Garcimartín, Anna Celli, Martina Sanlorenzo, Igor Vujic, Jeffrey Ma, Mitchell Zekhtser, Klemens Rappersberger, Susana Ortiz-Urda & Álvaro Somoza. (2014) DNA and aptamer stabilized gold nanoparticles for targeted delivery of anticancer therapeutics. Nanoscale 6:13, pages 7436-7442.
Crossref
Crossref
Daniéli Gerhardt, Gabriela Bertola, Fabrícia Dietrich, Fabrício Figueiró, Alfeu Zanotto-Filho, José Cláudio Moreira Fonseca, Fernanda Bueno Morrone, Carlos Henrique Barrios, Ana Maria O. Battastini & Christianne G. Salbego. (2014) Boldine induces cell cycle arrest and apoptosis in T24 human bladder cancer cell line via regulation of ERK, AKT, and GSK-3β. Urologic Oncology: Seminars and Original Investigations 32:1, pages 36.e1-36.e9.
Crossref
Crossref
A. Mortlock, K. Foote, J. Kettle & B. Aquila. 2014. Reference Module in Chemistry, Molecular Sciences and Chemical Engineering. Reference Module in Chemistry, Molecular Sciences and Chemical Engineering.
Michal Hershfinkel. 2014. Zinc Signals in Cellular Functions and Disorders. Zinc Signals in Cellular Functions and Disorders
111
133
.
Emily C. Benesh, Peter A. Humphrey, Qiang Wang & Kelle H. Moley. (2013) Maternal high-fat diet induces hyperproliferation and alters Pten/Akt signaling in prostates of offspring. Scientific Reports 3:1.
Crossref
Crossref
Dong-Ze Qiu, Zhou-Ji Zhang, Wei-Zhong Wu & Yun-Ke Yang. (2013) Bufalin, a component in Chansu, inhibits proliferation and invasion of hepatocellular carcinoma cells. BMC Complementary and Alternative Medicine 13:1.
Crossref
Crossref
Tom Wei-Wu Chen & Philippe L. Bedard. (2013) Personalized medicine for metastatic breast cancer. Current Opinion in Oncology 25:6, pages 615-624.
Crossref
Crossref
Jisoo Park, Yuwen Li, Seon-Hwan Kim, Gyeyeong Kong, Robin Shrestha, Quangdon Tran, Janghee Hong, Gang Min Hur, Brian A. Hemmings, Bon Seok Koo & Jongsun Park. (2013) Characterization of fragmented 3-phosphoinsitide-dependent protein kinase-1 (PDK1) by phosphosite-specific antibodies. Life Sciences 93:18-19, pages 700-706.
Crossref
Crossref
J Glauer, N Pletz, M Schön, P Schneider, N Liu, K Ziegelbauer, S Emmert, G G Wulf & M P Schön. (2013) A novel selective small-molecule PI3K inhibitor is effective against human multiple myeloma in vitro and in vivo. Blood Cancer Journal 3:9, pages e141-e141.
Crossref
Crossref
Soren Gantt, Corey Casper & Richard F. Ambinder. (2013) Insights into the broad cellular effects of nelfinavir and the HIV protease inhibitors supporting their role in cancer treatment and prevention. Current Opinion in Oncology 25:5, pages 495-502.
Crossref
Crossref
Liang Luo, Ying-Jian Sun & Yi-Jun Wu. (2013) Abamectin resistance in Drosophila is related to increased expression of P-glycoprotein via the dEGFR and dAkt pathways. Insect Biochemistry and Molecular Biology 43:8, pages 627-634.
Crossref
Crossref
Jan B. Egan, K. Martin Kortuem, Ahmet Kurdoglu, Tyler Izatt, Jessica Aldrich, Rebecca Reiman, Lori Phillips, Angela Baker, Chang‐Xin Shi, Jessica Schmidt, Winnie S. Liang, David W. Craig, John D. Carpten & A. Keith Stewart. (2013)
Extramedullary myeloma whole genome sequencing reveals novel mutations in
C
ereblon, proteasome subunit
G
2 and the glucocorticoid receptor in multi drug resistant disease
. British Journal of Haematology 161:5, pages 748-751.
Crossref
Crossref
William K.K. Wu, Xiao J. Wang, Alfred S.L. Cheng, Millore X.M. Luo, Simon S.M. Ng, Ka F. To, Francis K.L. Chan, Chi H. Cho, Joseph J.Y. Sung & Jun Yu. (2013) Dysregulation and crosstalk of cellular signaling pathways in colon carcinogenesis. Critical Reviews in Oncology/Hematology 86:3, pages 251-277.
Crossref
Crossref
Shuai Gao, Chen-Lin Hsieh, Meenakshi Bhansali, Archana Kannan & Lirim Shemshedini. (2013) A Peptide against Soluble Guanylyl Cyclase α1: A New Approach to Treating Prostate Cancer. PLoS ONE 8:5, pages e64189.
Crossref
Crossref
Konstantinos Kamposioras, George Pentheroudakis & Nicholas Pavlidis. (2013) Exploring the biology of cancer of unknown primary: breakthroughs and drawbacks. European Journal of Clinical Investigation 43:5, pages 491-500.
Crossref
Crossref
X. Qian, J. M. Song, T. Melkamu, P. Upadhyaya & F. Kassie. (2012) Chemoprevention of lung tumorigenesis by intranasally administered diindolylmethane in A/J mice. Carcinogenesis 34:4, pages 841-849.
Crossref
Crossref
Hong Lin. (2013) Isoform Selective PI3K‐beta Inhibitors. Chinese Journal of Chemistry 31:3, pages 299-303.
Crossref
Crossref
Stefan Hart, Veronica Novotny-Diermayr, Kee Chuan Goh, Meredith Williams, Yong Cheng Tan, Lai Chun Ong, Albert Cheong, Bee Kheng Ng, Chithra Amalini, Babita Madan, Harish Nagaraj, Ramesh Jayaraman, Khalid M. Pasha, Kantharaj Ethirajulu, Wee Joo Chng, Nurulhuda Mustafa, Boon Cher Goh, Cyril Benes, Ultan McDermott, Mathew Garnett, Brian Dymock & Jeanette M. Wood. (2013) VS-5584, a Novel and Highly Selective PI3K/mTOR Kinase Inhibitor for the Treatment of Cancer. Molecular Cancer Therapeutics 12:2, pages 151-161.
Crossref
Crossref
Giuseppe Floris, Agnieszka Wozniak, Raf Sciot, Haifu Li, Lori Friedman, Thomas Van Looy, Jasmien Wellens, Peter Vermaelen, Christophe M. Deroose, Jonathan A. Fletcher, Maria Debiec-Rychter & Patrick Schöffski. (2013) A Potent Combination of the Novel PI3K Inhibitor, GDC-0941, with Imatinib in Gastrointestinal Stromal Tumor Xenografts: Long-Lasting Responses after Treatment Withdrawal. Clinical Cancer Research 19:3, pages 620-630.
Crossref
Crossref
Alessandro Didonna. (2013) Prion protein and its role in signal transduction. Cellular and Molecular Biology Letters 18:2.
Crossref
Crossref
Jing-Ru Weng, Li-Yuan Bai, Chang-Fang Chiu, Jing-Lan Hu, Shih-Jiuan Chiu & Chia-Yung Wu. (2013)
Cucurbitane Triterpenoid from
Momordica charantia
Induces Apoptosis and Autophagy in Breast Cancer Cells, in Part, through Peroxisome Proliferator-Activated Receptor
γ
Activation
. Evidence-Based Complementary and Alternative Medicine 2013, pages 1-12.
Crossref
Crossref
Joseph J. Provost & Mark A. Wallert. (2013) Inside Out: Targeting NHE1 as an Intracellular and Extracellular Regulator of Cancer Progression. Chemical Biology & Drug Design 81:1, pages 85-101.
Crossref
Crossref
Luni Emdad, Swadesh K. Das, Santanu Dasgupta, Bin Hu, Devanand Sarkar & Paul B. Fisher. 2013. AEG-1/MTDH/LYRIC Implicated in Multiple Human Cancers. AEG-1/MTDH/LYRIC Implicated in Multiple Human Cancers
75
111
.
Showming Kwok, Nikolaos Mellios & Mriganka Sur. 2013. The Neuroscience of Autism Spectrum Disorders. The Neuroscience of Autism Spectrum Disorders
449
459
.
Simone Treiger Sredni, Abby L. Halpern, Christopher A. Hamm, Maria de Fátima Bonaldo & Tadanori Tomita. (2012) Histone deacetylases expression in atypical teratoid rhabdoid tumors. Child's Nervous System 29:1, pages 5-9.
Crossref
Crossref
Chieh-Hsiang Lu, Yi-Wen Liu, Shih-Che Hua, Hui-I. Yu, Yi-Ping Chang & Ying-Ray Lee. (2012) Autophagy induction of reversine on human follicular thyroid cancer cells. Biomedicine & Pharmacotherapy 66:8, pages 642-647.
Crossref
Crossref
Alberto M. Martelli, Giovanna Tabellini, Daniela Bressanin, Andrea Ognibene, Kaoru Goto, Lucio Cocco & Camilla Evangelisti. (2012) The emerging multiple roles of nuclear Akt. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1823:12, pages 2168-2178.
Crossref
Crossref
Hua Zhang, Yayun Qian, Yanqing Liu, Guoqing Li, Pingfang Cui, Yaodong Zhu, Hui Ma, Xue Ji, Shiyu Guo & Hisamits Tadashi. (2012) Celastrus orbiculatus extract induces mitochondrial-mediated apoptosis in human hepatocellular carcinoma cells. Journal of Traditional Chinese Medicine 32:4, pages 621-626.
Crossref
Crossref
Antonietta Melchini, Paul W. Needs, Richard F. Mithen & Maria H. Traka. (2012) Enhanced in Vitro Biological Activity of Synthetic 2-(2-Pyridyl) Ethyl Isothiocyanate Compared to Natural 4-(Methylsulfinyl) Butyl Isothiocyanate. Journal of Medicinal Chemistry 55:22, pages 9682-9692.
Crossref
Crossref
Yuan Liu, Qi Yin, Yao Yuan, Wenyong Yang, Chuangui Jiang & Canhua Huang. (2012) Infectomics Screening for Novel Antiviral Drug Targets. Drug Development Research 73:7, pages 365-380.
Crossref
Crossref
Nan Liu, Sheng Tai, Boxiao Ding, Ryan K Thor, Sunita Bhuta, Yin Sun & Jiaoti Huang. (2012) Arsenic trioxide synergizes with everolimus (Rad001) to induce cytotoxicity of ovarian cancer cells through increased autophagy and apoptosis. Endocrine-Related Cancer 19:5, pages 711-723.
Crossref
Crossref